Zepbound is indicated for adults with obesity (with a BMI of 30 kg/m2 or greater), or those who are overweight (with a BMI of 27 kg/m2 or greater) and also have weight-related medical problems such as hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea or cardiovascular disease, to lose weight and keep it off
Garcia-Contreras M, Thakor A
Its formulation promotes structured investigation and repeatable observations in different experimental models
Incorporate fruits, vegetables, and lean proteins to maintain energy levels and overall health
Is the BMI criterion enough for suitability
Ozempic (a GLP-1) is generally far more effective for significant weight loss, while Jardiance (an SGLT2 inhibitor) offers exceptional cardiovascular and kidney protection